ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2026
Published Date: 2026-04-13
|
Report Code: QYRE-Auto-10W17263
Home | Market Reports
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
BUY CHAPTERS

Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2026

Code: QYRE-Auto-10W17263
Report
2026-04-13
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Bayer
CSL Limited
Grifols S A
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer Inc
Octapharma AG
OMRIX Biopharmaceuticals
Shanghai Raas

Recombinant Human Thrombin for Surgical Hemostasis Market

The global Recombinant Human Thrombin for Surgical Hemostasis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Human Thrombin for Surgical Hemostasis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Recombinant Human Thrombin for Surgical Hemostasis is a medication or product that contains artificially produced human thrombin, which is used in surgical procedures to promote blood clotting and control bleeding. Thrombin is a protein involved in the blood clotting process, and when applied topically or locally during surgery, it helps to accelerate the formation of blood clots and stop bleeding. This product is commonly used in various surgical specialties, such as cardiovascular surgery, orthopedic surgery, and general surgery, to help achieve hemostasis and prevent excessive bleeding.
The North American market for Recombinant Human Thrombin for Surgical Hemostasis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Recombinant Human Thrombin for Surgical Hemostasis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Recombinant Human Thrombin for Surgical Hemostasis include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Recombinant Human Thrombin for Surgical Hemostasis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Human Thrombin for Surgical Hemostasis. The Recombinant Human Thrombin for Surgical Hemostasis market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Human Thrombin for Surgical Hemostasis market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Human Thrombin for Surgical Hemostasis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Recombinant Human Thrombin for Surgical Hemostasis Market Report

Report Metric Details
Report Name Recombinant Human Thrombin for Surgical Hemostasis Market
Segment by Type
  • Based Bovine
  • Based Human
  • Others
by Application
  • Hospitals
  • Diagnostics & Clinics
  • Academic and Research Institute
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Human Thrombin for Surgical Hemostasis manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Recombinant Human Thrombin for Surgical Hemostasis sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Human Thrombin for Surgical Hemostasis Market report?

Ans: The main players in the Recombinant Human Thrombin for Surgical Hemostasis Market are Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS

What are the Application segmentation covered in the Recombinant Human Thrombin for Surgical Hemostasis Market report?

Ans: The Applications covered in the Recombinant Human Thrombin for Surgical Hemostasis Market report are Hospitals, Diagnostics & Clinics, Academic and Research Institute

What are the Type segmentation covered in the Recombinant Human Thrombin for Surgical Hemostasis Market report?

Ans: The Types covered in the Recombinant Human Thrombin for Surgical Hemostasis Market report are Based Bovine, Based Human, Others

1 Recombinant Human Thrombin for Surgical Hemostasis Market Overview
1.1 Product Definition
1.2 Recombinant Human Thrombin for Surgical Hemostasis by Type
1.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Type: 2025 vs 2032
1.2.2 Based Bovine
1.2.3 Based Human
1.2.4 Others
1.3 Recombinant Human Thrombin for Surgical Hemostasis by Application
1.3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue 2021–2032
1.4.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales 2021–2032
1.4.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Human Thrombin for Surgical Hemostasis Market Competition by Manufacturers
2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Human Thrombin for Surgical Hemostasis Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Human Thrombin for Surgical Hemostasis, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Date of Entry into the Industry
2.8 Global Recombinant Human Thrombin for Surgical Hemostasis Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Human Thrombin for Surgical Hemostasis Players Market Share by Revenue
2.8.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Scenario by Region
3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region: 2021–2032
3.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region: 2021–2026
3.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region: 2027–2032
3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2021–2032
3.3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2021–2026
3.3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2027–2032
3.4 North America Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.4.1 North America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2021–2032)
3.4.3 North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2021–2032)
3.5.3 Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2021–2032)
4.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2021–2026)
4.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2027–2032)
4.1.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2021–2032)
4.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2021–2026)
4.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2027–2032)
4.2.3 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Human Thrombin for Surgical Hemostasis Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2021–2032)
5.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2021–2026)
5.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2027–2032)
5.1.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2021–2032)
5.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2021–2026)
5.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2027–2032)
5.2.3 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Human Thrombin for Surgical Hemostasis Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Company Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Hualan Biological
6.6.1 Hualan Biological Company Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.6.5 Hualan Biological Recent Developments/Updates
6.7 Haematologic Technologies
6.7.1 Haematologic Technologies Company Information
6.7.2 Haematologic Technologies Description and Business Overview
6.7.3 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.7.5 Haematologic Technologies Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Company Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Omrix Biopharmaceuticals
6.10.1 Omrix Biopharmaceuticals Company Information
6.10.2 Omrix Biopharmaceuticals Description and Business Overview
6.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.10.5 Omrix Biopharmaceuticals Recent Developments/Updates
6.11 Shanghai RAAS
6.11.1 Shanghai RAAS Company Information
6.11.2 Shanghai RAAS Description and Business Overview
6.11.3 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.11.5 Shanghai RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Thrombin for Surgical Hemostasis Industry Chain Analysis
7.2 Recombinant Human Thrombin for Surgical Hemostasis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Thrombin for Surgical Hemostasis Production Mode & Process Analysis
7.4 Recombinant Human Thrombin for Surgical Hemostasis Sales and Marketing
7.4.1 Recombinant Human Thrombin for Surgical Hemostasis Sales Channels
7.4.2 Recombinant Human Thrombin for Surgical Hemostasis Distributors
7.5 Recombinant Human Thrombin for Surgical Hemostasis Customer Analysis
8 Recombinant Human Thrombin for Surgical Hemostasis Market Dynamics
8.1 Recombinant Human Thrombin for Surgical Hemostasis Industry Trends
8.2 Recombinant Human Thrombin for Surgical Hemostasis Market Drivers
8.3 Recombinant Human Thrombin for Surgical Hemostasis Market Challenges
8.4 Recombinant Human Thrombin for Surgical Hemostasis Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda
Bayer
CSL Limited
Grifols S A
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer Inc
Octapharma AG
OMRIX Biopharmaceuticals
Shanghai Raas
List of Tables
 Table 1. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Recombinant Human Thrombin for Surgical Hemostasis Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Recombinant Human Thrombin for Surgical Hemostasis Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Recombinant Human Thrombin for Surgical Hemostasis, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Product Types and Applications
 Table 12. Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Thrombin for Surgical Hemostasis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Thrombin for Surgical Hemostasis Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (K Units), 2021–2026
 Table 18. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2021–2026)
 Table 19. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (K Units), 2027–2032
 Table 20. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2027–2032)
 Table 21. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2021–2026)
 Table 23. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2027–2032)
 Table 25. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2021–2026
 Table 27. North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2027–2032
 Table 28. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2021–2026
 Table 32. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2027–2032
 Table 33. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2021–2026
 Table 42. Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2027–2032
 Table 43. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Type (2021–2026)
 Table 51. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Type (2027–2032)
 Table 52. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2021–2026)
 Table 53. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2027–2032)
 Table 54. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2021–2026)
 Table 57. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2027–2032)
 Table 58. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Application (2021–2026)
 Table 61. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Application (2027–2032)
 Table 62. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2021–2026)
 Table 63. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2027–2032)
 Table 64. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2021–2026)
 Table 67. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2027–2032)
 Table 68. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Application (2027–2032)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Bayer Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. CSL Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Grifols Company Information
 Table 86. Grifols Description and Business Overview
 Table 87. Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Grifols Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 89. Grifols Recent Developments/Updates
 Table 90. GE Healthcare Company Information
 Table 91. GE Healthcare Description and Business Overview
 Table 92. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 94. GE Healthcare Recent Developments/Updates
 Table 95. Hualan Biological Company Information
 Table 96. Hualan Biological Description and Business Overview
 Table 97. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 99. Hualan Biological Recent Developments/Updates
 Table 100. Haematologic Technologies Company Information
 Table 101. Haematologic Technologies Description and Business Overview
 Table 102. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 104. Haematologic Technologies Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Octapharma Company Information
 Table 111. Octapharma Description and Business Overview
 Table 112. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 114. Octapharma Recent Developments/Updates
 Table 115. Omrix Biopharmaceuticals Company Information
 Table 116. Omrix Biopharmaceuticals Description and Business Overview
 Table 117. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 119. Omrix Biopharmaceuticals Recent Developments/Updates
 Table 120. Shanghai RAAS Company Information
 Table 121. Shanghai RAAS Description and Business Overview
 Table 122. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product
 Table 124. Shanghai RAAS Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Recombinant Human Thrombin for Surgical Hemostasis Distributors List
 Table 128. Recombinant Human Thrombin for Surgical Hemostasis Customers List
 Table 129. Recombinant Human Thrombin for Surgical Hemostasis Market Trends
 Table 130. Recombinant Human Thrombin for Surgical Hemostasis Market Drivers
 Table 131. Recombinant Human Thrombin for Surgical Hemostasis Market Challenges
 Table 132. Recombinant Human Thrombin for Surgical Hemostasis Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Thrombin for Surgical Hemostasis
 Figure 2. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Type: 2025 & 2032
 Figure 4. Based Bovine Product Picture
 Figure 5. Based Human Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application: 2025 & 2032
 Figure 9. Hospitals
 Figure 10. Diagnostics & Clinics
 Figure 11. Academic and Research Institute
 Figure 12. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (US$ Million), 2021–2032
 Figure 14. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), 2021–2032
 Figure 15. Global Recombinant Human Thrombin for Surgical Hemostasis Average Price (US$/Unit), 2021–2032
 Figure 16. Recombinant Human Thrombin for Surgical Hemostasis Report Years Considered
 Figure 17. Recombinant Human Thrombin for Surgical Hemostasis Sales Share by Manufacturers in 2025
 Figure 18. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Recombinant Human Thrombin for Surgical Hemostasis Players: Market Share by Revenue in Recombinant Human Thrombin for Surgical Hemostasis in 2025
 Figure 20. Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2021–2032)
 Figure 23. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2021–2032)
 Figure 24. United States Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2021–2032)
 Figure 27. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2021–2032)
 Figure 35. China Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2021–2032)
 Figure 55. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Application (2021–2032)
 Figure 58. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Application (2021–2032)
 Figure 59. Recombinant Human Thrombin for Surgical Hemostasis Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Recombinant Human Thrombin Protein Market Research Report 2024
Global Human Thrombin Market Research Report 2024
Global Topical Recombinant Human Thrombin Market Research Report 2024
Global Fibrin Glue Hemostat Market Research Report 2024
Recombinant Hirudin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Recombinant Thrombin Market Research Report 2024
Global Medical Topical Hemostatic Agent Market Research Report 2025
Human Fibrin Glue Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Activated Coagulation Factor VII Market Research Report 2025
Global Synthetic Hemostatic Products Market Research Report 2024
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor VII Market Insights Forecast to 2030
Global Surgical Hemostatic Material Market Research Report 2025
Global Reusable Hemostatic Valve Market Research Report 2024
Global Fibrin Sealant Product Market Research Report 2024
Hemostatic Clip Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostatic Gel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Surgical Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Materials in Wound Care Market Research Report 2024
Antithrombin Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions